Curtis Tyree

Svp, Strategy And Business Development at Organovo

Curtis Tyree has a diverse work experience in the biotechnology and pharmaceutical industries. Curtis currently holds the position of SVP, Strategy and Business Development at Organovo Holdings, Inc. and Viscient Bio Inc. Curtis has also worked at HUYABIO International, where they served as a Strategic Advisor and held various roles such as SVP, Strategic Planning and SVP, Operations, responsible for managing progress and evaluating therapeutic opportunities.

In addition, Curtis Tyree has served as a Member of the Advisory Board at Keck Graduate Institute (KGI), School of Pharmacy and as an Adjunct Clinical Assistant Professor of Pharmacy Practice at KGI School of Pharmacy and Health Sciences.

Furthermore, they founded Pertinent Advice Consulting, where they provided scientific portfolio management, competitive intelligence, and due diligence services for biotechnology and pharmaceutical companies. Curtis has also worked at TorreyPines Therapeutics as a Consultant, Director of Scientific Affairs, and Director of Lead Discovery.

Prior to these roles, Curtis Tyree worked as an Instructor at UCSD Extension and as a Senior Research Scientist at Ligand Pharmaceuticals. Curtis started their career as a Postdoctoral Fellow at the University of Wisconsin-Madison, where they conducted research on Epstein-Barr virus replication mechanisms.

Overall, Curtis Tyree has demonstrated their expertise in strategy, business development, operations, and scientific research throughout their career in the biotechnology and pharmaceutical sectors.

Curtis Tyree's education history begins in 1984 when they enrolled at McGill University. Curtis studied Microbiology and Immunology for four years and earned a Bachelor of Science (BSc) degree in 1988.

Following their undergraduate studies, Curtis pursued their Ph.D. in Biology at UC San Diego. Curtis started this program in 1988 and completed it in 1993.

In 1993, Curtis then pursued Postdoctoral Studies at the University of Wisconsin-Madison, specializing in Oncology and Cancer Biology. Curtis completed this program in 1996.

Additionally, Curtis also holds a Doctor of Philosophy (PhD) degree in Molecular Biology, which was obtained at UC San Diego. The specific start and end year for this degree are not provided.

Overall, Curtis' education history includes a Bachelor of Science degree in Microbiology and Immunology from McGill University, a Ph.D. in Biology from UC San Diego, and Postdoctoral Studies in Oncology and Cancer Biology from the University of Wisconsin-Madison. Curtis also has a Doctor of Philosophy (PhD) in Molecular Biology from UC San Diego.

Links

Previous companies

Ligand Pharmaceuticals logo

Timeline

  • Svp, Strategy And Business Development

    February, 2022 - present

View in org chart